A new DRUG TRIALS SNAPSHOT FOR ZINBRYTA is now available.
ZINBRYTA is a drug for the treatment of relapsing forms of multiple sclerosis (MS) in patients who have not responded adequately to at least 2 other treatments for MS.
Drug Trials Snapshots provide information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.
No hay comentarios:
Publicar un comentario